How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

11,595 results for

Intrauterine Device

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

161. Comparison Between 2 Doses of Misoprostol Before Intrauterine Device

Comparison Between 2 Doses of Misoprostol Before Intrauterine Device Comparison Between 2 Doses of Misoprostol Before Intrauterine Device - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Comparison Between 2 (...) Doses of Misoprostol Before Intrauterine Device The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02901561 Recruitment Status : Completed First Posted : September 15, 2016 Last Update Posted : March 14, 2017 Sponsor: Assiut University Information provided by (Responsible Party): Ahmed Mohamed Abbas

2016 Clinical Trials

162. Indomethacin Use in Pain Relief During Intrauterine Device Insertion

Indomethacin Use in Pain Relief During Intrauterine Device Insertion Indomethacin Use in Pain Relief During Intrauterine Device Insertion - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Indomethacin Use (...) in Pain Relief During Intrauterine Device Insertion (INDO-IUD) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02711358 Recruitment Status : Completed First Posted : March 17, 2016 Last Update Posted : November 29, 2016 Sponsor: Assiut University Information provided by (Responsible Party): Ahmed

2016 Clinical Trials

163. Expulsion of Immediate Postplacental Copper Intrauterine Devices at Six Months: A Prospective Cohort Study

Expulsion of Immediate Postplacental Copper Intrauterine Devices at Six Months: A Prospective Cohort Study Expulsion of Immediate Postplacental Copper Intrauterine Devices at Six Months: A Prospective Cohort Study - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100 (...) ). Please remove one or more studies before adding more. Expulsion of Immediate Postplacental Copper Intrauterine Devices at Six Months: A Prospective Cohort Study (PPIUD) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02706340 Recruitment Status : Completed First Posted : March 11, 2016 Last Update

2016 Clinical Trials

164. Oral Diclofenac Sodium Versus Oral Hyoscine Butyl Bromide During Intrauterine Device Insertion

Oral Diclofenac Sodium Versus Oral Hyoscine Butyl Bromide During Intrauterine Device Insertion Oral Diclofenac Sodium Versus Oral Hyoscine Butyl Bromide During Intrauterine Device Insertion - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one (...) or more studies before adding more. Oral Diclofenac Sodium Versus Oral Hyoscine Butyl Bromide During Intrauterine Device Insertion The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02714231 Recruitment Status : Completed First Posted : March 21, 2016 Last Update Posted : July 19, 2017 Sponsor: Assiut

2016 Clinical Trials

165. A Study to Compare the Menstrual Bleeding Profile Among Jaydess® and Copper Intrauterine Device (IUD) Users. COLIBRI STUDY (Copper and Levonorgestrel IUD Barcelona Research Initiative).

A Study to Compare the Menstrual Bleeding Profile Among Jaydess® and Copper Intrauterine Device (IUD) Users. COLIBRI STUDY (Copper and Levonorgestrel IUD Barcelona Research Initiative). A Study to Compare the Menstrual Bleeding Profile Among Jaydess® and Copper Intrauterine Device (IUD) Users. COLIBRI STUDY (Copper and Levonorgestrel IUD Barcelona Research Initiative). - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration (...) or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Study to Compare the Menstrual Bleeding Profile Among Jaydess® and Copper Intrauterine Device (IUD) Users. COLIBRI STUDY (Copper and Levonorgestrel IUD Barcelona Research Initiative). (COLIBRI) The safety and scientific validity of this study is the responsibility of the study sponsor

2016 Clinical Trials

166. Efficacy of Ketoprofen Before Intrauterine Device Insertion

Efficacy of Ketoprofen Before Intrauterine Device Insertion Efficacy of Ketoprofen Before Intrauterine Device Insertion - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Efficacy of Ketoprofen Before (...) Intrauterine Device Insertion The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02905058 Recruitment Status : Completed First Posted : September 19, 2016 Last Update Posted : November 14, 2017 Sponsor: Assiut University Information provided by (Responsible Party): Ahmed Mohamed Abbas, Assiut University Study

2016 Clinical Trials

167. Comparison Between Intrauterine Contraceptive Device Insertion During Cesarean Section Vs Conventional Application

Comparison Between Intrauterine Contraceptive Device Insertion During Cesarean Section Vs Conventional Application Comparison Between Intrauterine Contraceptive Device Insertion During Cesarean Section Vs Conventional Application - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number (...) of saved studies (100). Please remove one or more studies before adding more. Comparison Between Intrauterine Contraceptive Device Insertion During Cesarean Section Vs Conventional Application The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02674139 Recruitment Status : Unknown Verified September 2016

2016 Clinical Trials

168. The Effect of Intrauterine Devices on Acquisition and Clearance of Human Papillomavirus. (PubMed)

The Effect of Intrauterine Devices on Acquisition and Clearance of Human Papillomavirus. Previous studies have shown a decrease in cervical cancer associated with intrauterine device use. It has been hypothesized that intrauterine device use may alter the natural history of human papillomavirus infections, preempting development of precancerous lesions of the cervix and cervical cancer, but the effect of intrauterine devices on the natural history of human papillomavirus infection (...) and subsequent development of cervical cancer is poorly understood.The purpose of this study was to evaluate the association between intrauterine device use and cervical high-risk human papillomavirus acquisition and clearance.This is a prospective cohort study conducted from October 2000 through June 2014 among 676 sexually active young women and girls enrolled from family planning clinics in San Francisco, CA. Data were analyzed using a Cox proportional hazards model, including time-varying indicators

Full Text available with Trip Pro

2016 American Journal of Obstetrics and Gynecology

169. Chronic vulvovaginal candidiasis in patients using a levonorgestrel-containing intrauterine device. (PubMed)

Chronic vulvovaginal candidiasis in patients using a levonorgestrel-containing intrauterine device. Chronic vulvovaginal candidiasis is usually responsive to therapy with oral antifungals. We present a case series of 13 patients with this condition who were also using a levonorgestrel intrauterine system (LNG-IUS). All cases responded to ongoing oral fluconazole therapy while the LNG-IUS was in situ. The LNG-IUS was removed in six patients and of these, two experienced clinical improvement

2016 Australasian Journal of Dermatology

170. Naproxen Sodium for Pain Control With Intrauterine Device Insertion: A Randomized Controlled Trial. (PubMed)

Naproxen Sodium for Pain Control With Intrauterine Device Insertion: A Randomized Controlled Trial. To evaluate whether 550 mg oral naproxen sodium given 1 hour before intrauterine device (IUD) insertion is effective for pain relief as compared with placebo.This was a randomized, double-blind, placebo-controlled trial. The primary outcome was pain with IUD insertion measured on a 100-mm visual analog scale (VAS). Our sample size was calculated to detect a 15-mm difference in VAS scores with 80

2016 Obstetrics and Gynecology

171. Effect of cervical lidocaine-prilocaine cream on pain perception during copper T380A intrauterine device insertion among parous women: A randomized double-blind controlled trial. (PubMed)

Effect of cervical lidocaine-prilocaine cream on pain perception during copper T380A intrauterine device insertion among parous women: A randomized double-blind controlled trial. The objective was to investigate the analgesic effect of cervical lidocaine-prilocaine (LP) cream in alleviating pain during copper T380A intrauterine device (IUD) insertion among parous women.We conducted a randomized, double-blind, placebo-controlled trial at Assiut Women's Health Hospital, Egypt, from October 2015

2016 Contraception

172. Institutionalizing postpartum intrauterine device (IUD) services in Sri Lanka, Tanzania, and Nepal: study protocol for a cluster-randomized stepped-wedge trial. (PubMed)

Institutionalizing postpartum intrauterine device (IUD) services in Sri Lanka, Tanzania, and Nepal: study protocol for a cluster-randomized stepped-wedge trial. During the year following the birth of a child, 40% of women are estimated to have an unmet need for contraception. The copper IUD provides safe, effective, convenient, and long-term contraceptive protection that does not interfere with breastfeeding during the postpartum period. Postpartum IUD (PPIUD) insertion should be performed

Full Text available with Trip Pro

2016 BMC Pregnancy and Childbirth

173. Lidocaine 10% spray to the cervix reduces pain during intrauterine device insertion: a double-blind randomised controlled trial. (PubMed)

Lidocaine 10% spray to the cervix reduces pain during intrauterine device insertion: a double-blind randomised controlled trial. Fear of pain during intrauterine device (IUD) insertion can be a barrier to widespread use of this safe and highly effective contraceptive method. Our objective was to determine the effectiveness of topical 10% lidocaine spray for pain control during IUD insertion.A total of 200 subjects with the request for IUD insertion were included in the study. The patients were

Full Text available with Trip Pro

2016 Journal of Family Planning and Reproductive Health Care

174. Reasons for Intrauterine Device Use, Discontinuation and Non-Use in Malawi: A Qualitative Study of Women and their Partners. (PubMed)

Reasons for Intrauterine Device Use, Discontinuation and Non-Use in Malawi: A Qualitative Study of Women and their Partners. The copper intrauterine device (IUD) is a safe, long-acting, and effective method of contraception that is under-utilized in many countries, including Malawi. A unique cohort of women who had enrolled in a trial of postpartum IUD use one year earlier gave insights into reasons for using, discontinuing, or not using the IUD. We conducted in-depth interviews with 18 women

2016 African journal of reproductive health

175. Intrauterine Device Insertion Failure After Misoprostol Administration: A Systematic Review. (PubMed)

Intrauterine Device Insertion Failure After Misoprostol Administration: A Systematic Review. To examine rates of intrauterine device (IUD) insertion failure with and without prior misoprostol administration. Additional outcomes included difficulty of insertion, subjective pain, expulsion, and complications.Systematic searches were performed in PubMed MEDLINE, Cochrane Central Register of Controlled Trials, ClinicalTrials.gov, and Cumulative Index to Nursing and Allied Health Literature (...) for articles with the following keywords: "misoprostol," "intrauterine devices," and "IUDs."A total of 161 unique results were retrieved. Titles, abstracts, and full-text articles were independently screened twice by two reviewers for content and relevance. Quality assessment was performed using previously established criteria. After screening and quality assessment, nine randomized controlled trials (RCTs) were obtained for inclusion. Six articles were designated high quality and three were designated low

2016 Obstetrics and Gynecology

176. New developments in long-acting reversible contraception: the promise of intrauterine devices and implants to improve family planning services. (PubMed)

New developments in long-acting reversible contraception: the promise of intrauterine devices and implants to improve family planning services. After decades of having the developed world's highest rates of unintended pregnancy, the United States finally shows signs of improvement. This progress is likely due in large part to increased use of highly effective long-acting reversible methods of contraception. These methods can be placed and do not require any maintenance to provide years

2016 Fertility and Sterility

177. Comfort With Skills and Knowledge After Immediate Postpartum Intrauterine Device Training. (PubMed)

Comfort With Skills and Knowledge After Immediate Postpartum Intrauterine Device Training. To estimate whether a standardized immediate postpartum intrauterine device (IUD) simulation results in sustained improvement in perceived comfort with procedural skills.From November 2013 to April 2015, obstetric health care providers at two teaching hospitals participated in a 30-minute immediate postpartum IUD simulation workshop and program evaluation. We assessed knowledge of indications, insertion

2016 Obstetrics and Gynecology

178. Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial. (PubMed)

Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial. The copper intrauterine device (IUD) is under-utilised in South Africa, where injectable progestin contraception (IPC) dominates contraception usage. There is a lack of robust comparative data on these contraceptive options to inform policy, programs

Full Text available with Trip Pro

2016 Reproductive health

179. Use of effective contraception six months after emergency contraception with a copper intrauterine device or ulipristal acetate - a prospective observational cohort study. (PubMed)

Use of effective contraception six months after emergency contraception with a copper intrauterine device or ulipristal acetate - a prospective observational cohort study. Emergency contraception must be followed by the use of an effective method of contraception in order to reduce future risk of unintended pregnancies. Provision of long-acting reversible contraception (LARC) is highly effective in this regard. The aim of our study was to compare use of an effective method of contraception 6 (...) months following insertion of a copper intrauterine device (Cu-IUD) or intake of ulipristal acetate (UPA) for emergency contraception (EC).Women (n = 79) presenting with need for EC at an outpatient midwifery clinic chose either Cu-IUD or UPA according to preference. Follow up was 3 and 6 months later through telephone interviews. Primary outcome was use of an effective contraceptive method at the 6-month follow up. Secondary outcomes included use of an effective contraceptive method at 3 months

2016 Acta Obstetricia et Gynecologica Scandinavica

180. Safety and Efficacy of a 52 mg Levonorgestrel-medicated intrauterine device: A Seven Year Randomized Comparative Study with the TCu380A. (PubMed)

Safety and Efficacy of a 52 mg Levonorgestrel-medicated intrauterine device: A Seven Year Randomized Comparative Study with the TCu380A. To compare rates of unintended pregnancy, method continuation and reasons for removal among women using the 52-mg levonorgestrel (daily release 20 microg) levonorgestrel IUD (LNG-IUD) or the copper T 380A (TCu380A) intrauterine device.This was an open-label 7-year randomized controlled trial in 20 centres, 11 of which in China. Data on 1884 women with interval (...) ] per 100), particularly in Chinese women and, for the TCu380A, increased bleeding (9.9 [0.9] per 100), especially among non-Chinese women. Removal rates for pain were similar for the two intrauterine devices (IUDs). Cumulative rates of removal for symptoms compatible with hormonal side effects were 5.7 (0.7) and 0.4 (0.2) per 100 for the LNG-IUD and TCu380A, respectively, and cumulative losses to follow-up at 7 years were 26.0 (1.4) and 36.9 (1.3) per 100, respectively.The LNG-IUD and the TCu380A

Full Text available with Trip Pro

2016 Contraception

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>